FDA 483 - Columbia University Fertility Center - July 23, 2019

An FDA inspection of Columbia University Fertility Center identified a significant lapse in donor screening practices. The facility deemed an oocyte donor eligible despite her having risk factors for Zika virus infection. This resulted in the donation and subsequent use or cryopreservation of oocytes from a potentially at-risk donor.